$1.12
0.021.82%
At Close: -
$1.15
0.032.68%
After Hours: Jul 25, 4:24 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Co-Diagnostics (NASDAQ:CODX) Stock, Analyst Ratings, Price Targets, Forecasts
Co-Diagnostics Inc has a consensus price target of $3.5 based on the ratings of 2 analysts. The high is $5 issued by Sidoti & Co. on August 12, 2022. The low is $2 issued by HC Wainwright & Co. on June 17, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 17, 2024, May 13, 2024, and March 15, 2024, respectively. With an average price target of $2.17 between HC Wainwright & Co., there's an implied 88.41% upside for Co-Diagnostics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Sidoti & Co.
1calculated from analyst ratings
Analyst Ratings for Co-Diagnostics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/17/2024 | Buy Now | 73.91% | HC Wainwright & Co. | Yi Chen | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 05/13/2024 | Buy Now | 73.91% | HC Wainwright & Co. | Yi Chen | $2.5 → $2 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | 117.39% | HC Wainwright & Co. | Yi Chen | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 12/29/2023 | Buy Now | 160.87% | HC Wainwright & Co. | Yi Chen | → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 11/13/2023 | Buy Now | 160.87% | HC Wainwright & Co. | Yi Chen | $2 → $3 | Maintains | Neutral | Get Alert |
| 08/14/2023 | Buy Now | 73.91% | HC Wainwright & Co. | Yi Chen | $3 → $2 | Maintains | Neutral | Get Alert |
| 05/15/2023 | Buy Now | 160.87% | HC Wainwright & Co. | Yi Chen | → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 03/20/2023 | Buy Now | 160.87% | HC Wainwright & Co. | Yi Chen | $6 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 02/23/2023 | Buy Now | 421.74% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | → Buy | Get Alert |
| 11/14/2022 | Buy Now | 421.74% | HC Wainwright & Co. | Yi Chen | $9 → $6 | Maintains | Buy | Get Alert |
| 08/15/2022 | Buy Now | 682.61% | HC Wainwright & Co. | Yi Chen | $12 → $9 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | 334.78% | Sidoti & Co. | James Sidoti | → $5 | Downgrade | Buy → Neutral | Get Alert |
| 05/16/2022 | Buy Now | 943.48% | HC Wainwright & Co. | Yi Chen | $15 → $12 | Maintains | Buy | Get Alert |
| 11/12/2021 | Buy Now | 1204.35% | HC Wainwright & Co. | Yi Chen | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Co-Diagnostics (CODX) stock?
The latest price target for Co-Diagnostics (NASDAQ:CODX) was reported by HC Wainwright & Co. on June 17, 2024. The analyst firm set a price target for $2.00 expecting CODX to rise to within 12 months (a possible 73.91% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Co-Diagnostics (CODX)?
The latest analyst rating for Co-Diagnostics (NASDAQ:CODX) was provided by HC Wainwright & Co., and Co-Diagnostics reiterated their neutral rating.
When was the last upgrade for Co-Diagnostics (CODX)?
There is no last upgrade for Co-Diagnostics
When was the last downgrade for Co-Diagnostics (CODX)?
The last downgrade for Co-Diagnostics Inc happened on March 20, 2023 when HC Wainwright & Co. changed their price target from $6 to $3 for Co-Diagnostics Inc.
When is the next analyst rating going to be posted or updated for Co-Diagnostics (CODX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Co-Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Co-Diagnostics was filed on June 17, 2024 so you should expect the next rating to be made available sometime around June 17, 2025.
Is the Analyst Rating Co-Diagnostics (CODX) correct?
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a reiterated with a price target of $2.00 to $2.00. The current price Co-Diagnostics (CODX) is trading at is $1.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.